3 Things You Should Watch For in CVS Health's Q2 Update
A rebuilding year.
That's how CVS Health (NYSE: CVS) CEO Larry Merlo has referenced 2017 in the past. The rebuilding is needed because the large pharmacy services company lost two major contracts in the final four months of 2016 to rival Walgreens Boots Alliance (NASDAQ: WBA).
CVS Health started out 2017 by posting better-than-expected earnings in the first quarter. The company announces its second-quarter results on Aug. 8. Here are three things you should watch for in CVS Health's quarterly update.
Source: Fool.com
CVS Health Corp. Aktie
56,19 €
3,77 %
Klare Kaufstimmung: CVS Health Corp. hat 27 Buy-Einschätzungen und keine Sell-Einschätzung.
Ein Kursziel von 79 € für CVS Health Corp. würde eine Steigerung von mehr als 20% gegenüber dem aktuellen Kurs von 56.19 € bedeuten.
